Biblio Discovery — Demo Discovery Service

14 results for "Graham P. Cook"

Showing 1–14 · 0.02 seconds · RSS

  1. Journal Article Full text

    Multi-scale simulations of the T cell receptor reveal its lipid interactions, dynamics and the arrangement of its cytoplasmic region.

    Dheeraj Prakaash; Graham P Cook; Oreste Acuto et al.

    PLoS Computational Biology, Vol. 17 No. 7 · 2021 · English · DOAJ Scopus

    The T cell receptor (TCR-CD3) initiates T cell activation by binding to peptides of Major Histocompatibility Complexes (pMHC). The TCR-CD3 topology is well understood but the arrangement and dynamics of its cytoplasmic tails remains unknown, limiting our grasp of the signalling mechanism. Here, we…

    Also available at: PLOS

  2. Journal Article

    Molecular dynamics simulations reveal membrane lipid interactions of the full-length lymphocyte specific kinase (Lck)

    Dheeraj Prakaash; Charline Fagnen; Graham P. Cook et al.

    Scientific Reports, Vol. 12 No. 1 · 2022 · English · DOAJ Scopus

    Abstract The membrane-bound lymphocyte-specific protein-tyrosine kinase (Lck) triggers T cell antigen receptor signalling to initiate adaptive immune responses. Despite many structure–function studies, the mode of action of Lck and the potential role of plasma membrane lipids in regulating Lck’s…

  3. Journal Article

    TGFβ limits Myc-dependent TCR-induced metabolic reprogramming in CD8+ T cells

    Helen Carrasco Hope; Gabriella Pickersgill; Pierpaolo Ginefra et al.

    Frontiers in Immunology, Vol. 13 · 2022 · English · DOAJ Scopus

    T cell activation is dependent upon the integration of antigenic, co-stimulatory and cytokine-derived signals and the availability and acquisition of nutrients from the environment. Furthermore, T cell activation is accompanied by reprogramming of cellular metabolism to provide the energy and…

  4. Journal Article

    Non-redundant activity of GSK-3α and GSK-3β in T cell-mediated tumor rejection

    Lynette Steele; Aarren J. Mannion; Gary Shaw et al.

    iScience, Vol. 24 No. 6 · 2021 · English · DOAJ Scopus

    Summary: Glycogen synthase kinase-3 (GSK-3) is a positive regulator of PD-1 expression in CD8+ T cells and GSK-3 inhibition enhances T cell function and is effective in the control of tumor growth. GSK-3 has two co-expressed isoforms, GSK-3α and GSK-3β. Using conditional gene targeting, we…

  5. Journal Article

    Pro- and anti-tumour activities of CD146/MCAM in breast cancer result from its heterogeneous expression and association with epithelial to mesenchymal transition

    Aarren J. Mannion; Adam F. Odell; Syed Murtuza Baker et al.

    Frontiers in Cell and Developmental Biology, Vol. 11 · 2023 · English · DOAJ Scopus

    CD146, also known as melanoma cell adhesion molecule (MCAM), is expressed in numerous cancers and has been implicated in the regulation of metastasis. We show that CD146 negatively regulates transendothelial migration (TEM) in breast cancer. This inhibitory activity is reflected by a reduction in…

  6. Journal Article

    Phospho-enol pyruvate carboxykinase inhibition limits effector function in inflammatory T cells

    Rebecca J. Brownlie; Helen Carrasco Hope; David Wright et al.

    Frontiers in Immunology, Vol. 17 · 2026 · English · DOAJ Scopus

    IntroductionFollowing antigenic stimulation, T cells switch from a catabolic metabolic state maintained by low levels of nutrient uptake to an anabolic metabolism that sustains the biosynthetic and energetic demands of clonal expansion, differentiation, and effector function. Much progress has been…

  7. Journal Article Full text

    Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.

    Erica B Wilson; Jehan J El-Jawhari; Abbie L Neilson et al.

    PLoS ONE, Vol. 6 No. 9 · 2011 · English · DOAJ Scopus

    Immune evasion is now recognized as a key feature of cancer progression. In animal models, the activity of cytotoxic lymphocytes is suppressed in the tumour microenvironment by the immunosuppressive cytokine, Transforming Growth Factor (TGF)-β. Release from TGF-β-mediated inhibition restores…

    Also available at: PLOS

  8. Journal Article

    Enhancing oncolytic virotherapy by extracellular vesicle mediated microRNA reprogramming of the tumour microenvironment

    Victoria A. Jennings; Reah Rumbold-Hall; Gemma Migneco et al.

    Frontiers in Immunology, Vol. 15 · 2024 · English · DOAJ Scopus

    BackgroundThere has been limited success of cancer immunotherapies in the treatment of ovarian cancer (OvCa) to date, largely due to the immunosuppressive tumour microenvironment (TME). Tumour-associated macrophages (TAMs) are a major component of both the primary tumour and malignant ascites…

  9. Journal Article Full text

    Site-directed M2 proton channel inhibitors enable synergistic combination therapy for rimantadine-resistant pandemic influenza

    Claire Scott; Jayakanth Kankanala; Toshana L. Foster et al.

    PLOS Pathogens, Vol. 16 No. 8 · 2020 · English · PLOS Scopus

    Pandemic influenza A virus (IAV) remains a significant threat to global health. Preparedness relies primarily upon a single class of neuraminidase (NA) targeted antivirals, against which resistance is steadily growing. The M2 proton channel is an alternative clinically proven antiviral target, yet…

    Also available at: DOAJ